Two Alzheimer's patients with disabling depression failed to respond to
standard antidepressants but improved with a monoamine oxidase inhibitor.
The author points out that the cholinergic system is involved in
Alzheimer's symptoms and that demented patients have high monoamine oxidase
levels.
Abstract Teaser